DRD2
MOLECULAR TARGETdopamine receptor D2
DRD2 (dopamine receptor D2) is targeted by 114 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting DRD2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 114 compounds. Use the BiohacksAI search to explore all DRD2 modulators.
About DRD2 as a Drug Target
DRD2 (dopamine receptor D2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 114 compounds with documented DRD2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
DRD2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.